190 related articles for article (PubMed ID: 34036437)
21. Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.
Guo P; Liu P; Yang J; Ren T; Xiang Y
Cancer Manag Res; 2018; 10():3955-3961. PubMed ID: 30310316
[TBL] [Abstract][Full Text] [Related]
22. [Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature].
Omnes S; Morice P; Camatte S; Rouzier R; Pautier P; Pomel C; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Gynecol Obstet Fertil; 2003 Nov; 31(11):912-9. PubMed ID: 14623554
[TBL] [Abstract][Full Text] [Related]
23. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
[TBL] [Abstract][Full Text] [Related]
24. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
Reed W; Abeler VM; Tropé CG
Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
[TBL] [Abstract][Full Text] [Related]
25. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study of 16 cases of villoglandular adenocarcinoma of uterine cervix].
Zhu X; Wu M; Tan X; Yu Q
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(7):519-22. PubMed ID: 25916928
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
Chen JH; Duan H; Yu XB; Zhao HW; Chen X; Li P; Li ZQ; Li BX; Pan LY; Yan X; Chen C
Int J Gynecol Cancer; 2021 Apr; 31(4):512-517. PubMed ID: 33608452
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
29. Villoglandular Adenocarcinoma of the Uterine Cervix: A Case Report.
Park S; Pak MG; Park JW
J Menopausal Med; 2023 Dec; 29(3):150-153. PubMed ID: 38230601
[TBL] [Abstract][Full Text] [Related]
30. Villoglandular adenocarcinoma of the cervix: cytologic presentation.
Novotny DB; Ferlisi P
Diagn Cytopathol; 1997 Nov; 17(5):383-7. PubMed ID: 9360053
[TBL] [Abstract][Full Text] [Related]
31. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
32. Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?
Ramirez PT; Pareja R; Rendón GJ; Millan C; Frumovitz M; Schmeler KM
Gynecol Oncol; 2014 Jan; 132(1):254-9. PubMed ID: 24041877
[TBL] [Abstract][Full Text] [Related]
33. Conservative treatment of stage IA1 adenocarcinoma of the uterine cervix with a long-term follow-up.
Yahata T; Nishino K; Kashima K; Sekine M; Fujita K; Sasagawa M; Honma S; Kodama S; Tanaka K
Int J Gynecol Cancer; 2010 Aug; 20(6):1063-6. PubMed ID: 20683418
[TBL] [Abstract][Full Text] [Related]
34. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women.
Ostör A; Rome R; Quinn M
Obstet Gynecol; 1997 Jan; 89(1):88-93. PubMed ID: 8990445
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
36. The safety of fertility preservation for microinvasive cervical adenocarcinoma: a meta-analysis and trial sequential analysis.
Feng Y; Zhang Z; Lou T; Wang S; Bai H; Zhang Z
Arch Gynecol Obstet; 2018 Sep; 298(3):465-475. PubMed ID: 29876746
[TBL] [Abstract][Full Text] [Related]
37. Laparoscopic nerve-sparing radical hysterectomy without uterine manipulator for cervical cancer stage IB: description of the technique, our experience and results after the era of LACC trial.
Kavallaris A; Chalvatzas N; Gkoutzioulis A; Zygouris D
Arch Gynecol Obstet; 2021 Apr; 303(4):1039-1047. PubMed ID: 33068159
[TBL] [Abstract][Full Text] [Related]
38. Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.
Tseng JH; Aloisi A; Sonoda Y; Gardner GJ; Zivanovic O; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2018 Jul; 150(1):44-49. PubMed ID: 29776598
[TBL] [Abstract][Full Text] [Related]
39. Villoglandular papillary adenocarcinoma of the uterine cervix with aggressive clinical course--a case report.
Rubesa-Mihaljević R; Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Sindik N; Krasević M
Coll Antropol; 2010 Mar; 34(1):291-4. PubMed ID: 20437645
[TBL] [Abstract][Full Text] [Related]
40. Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.
Kuznicki ML; Chambers LM; Morton M; Son J; Horowitz M; Crean-Tate KK; Hackett L; Rose PG
J Minim Invasive Gynecol; 2021 Mar; 28(3):513-526.e1. PubMed ID: 33223017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
